Case Report: Self-Administration of Omalizumab in an Adolescent With Severe Asthma During SARS-CoV-2 Infection
Acute asthma remains one of the most frequent causes of children's access to healthcare. Asthma exacerbation is an essential defining characteristic of its severity, and respiratory infections entail increased risks of exacerbations with potential hospitalization. In the literature, contradicto...
Saved in:
Main Authors: | Erika Paladini (Author), Mattia Giovannini (Author), Simona Barni (Author), Giulia Liccioli (Author), Lucrezia Sarti (Author), Elio Novembre (Author), Francesca Mori (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Omalizumab and mepolizumab in the landscape of biological therapy for severe asthma in children: how to choose?
by: Mattia Giovannini, et al.
Published: (2019) -
From the Global Initiative for Asthma report and asthma guidelines to real-life asthma control: is there room for improvement?
by: Elio Novembre, et al.
Published: (2022) -
Acute FPIES and DIES: is a G lacking?
by: Elio Novembre, et al.
Published: (2023) -
Venom immunotherapy protocols in the pediatric population: how to choose?
by: Francesca Saretta, et al.
Published: (2023) -
Response to: 'Failed oral immunotherapy should be considered as a risk factor for fatal anaphylaxis, and omalizumab treatment considered'
by: Elio Novembre, et al.
Published: (2024)